At a glance
ClinicalIndex Comparison RecordN/ACompleted· 6 enrolled
Drug / intervention
Impedance measurementsother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Identification of Clinically Relevant Markers of Deep Brain Stimulation Electrode Impedance
In Brief
A clinical study evaluating Impedance measurements for Parkinson Disease. Completed, enrolled 6 participants across 1 site.
Detailed Summary
The study will look into the changes of Deep Brain Stimulation (DBS) measured impedances in patients of Parkinson disease (PD) as a function of their functional state (lying, sitting and walking) and dopaminergic medication intake (levodopa or dopamine agonists). The goal is to use DBS measured impedance as a surrogate of the functional and medication states of PD patients.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsParkinson Disease
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedJun 2016
Enrollment StartJul 2016
Primary CompletionJun 2017
TodayJul 2026
First PostedJun 9, 2016
Enrollment StartJul 1, 2016
Primary CompletionJun 1, 2017
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 10.1 years ago
Interventions
Impedance measurementsother
Refer to study description